scout
|Videos|October 19, 2017

Dr. Metz on Somatostatin Analogs and Emerging Agents in NETs Landscape

David C. Metz, MD, PhD, associate chief for Clinical Affairs, Gastrointestinal Division, Penn Medicine, University of Pennsylvania, discusses the utility of somatostatin analogs and emerging agents in the landscape of neuroendocrine tumors (NETs).

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME